Aarti Drugs Limited (NSE:AARTIDRUGS)

Aarti Drugs Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 4, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	44,993	31,240	39,886	31,280	39,725	64,755
Market Cap Growth	-9.07%	-21.68%	27.51%	-21.26%	-38.65%	449.47%
Enterprise Value	50,921	36,849	45,531	36,863	44,228	67,914
Last Close Price	489.45	340.30	433.27	336.30	426.18	688.25
PE Ratio	23.83	18.58	23.27	18.81	19.38	23.09
PS Ratio	1.86	1.31	1.58	1.15	1.60	3.01
PB Ratio	3.29	2.28	3.11	2.62	3.83	7.09
P/TBV Ratio	3.30	2.29	3.20	2.68	3.83	7.09
P/FCF Ratio	-	46.34	30.08	-	-	97.06
P/OCF Ratio	-	12.77	11.11	23.46	56.42	41.79
EV/Sales Ratio	2.10	1.54	1.80	1.36	1.78	3.15
EV/EBITDA Ratio	17.22	12.84	14.50	12.17	13.19	15.67
EV/EBIT Ratio	21.37	15.93	17.18	14.44	15.34	17.50
EV/FCF Ratio	-	54.66	34.34	-	-	101.79
Debt / Equity Ratio	0.45	0.45	0.44	0.51	0.52	0.38
Debt / EBITDA Ratio	2.08	2.14	1.79	1.99	1.60	0.80
Debt / FCF Ratio	-	9.12	4.26	-	-	5.26
Asset Turnover	-	0.95	1.04	1.17	1.25	1.29
Inventory Turnover	-	3.22	3.39	3.67	3.62	3.60
Quick Ratio	-	0.94	0.92	0.94	0.84	0.97
Current Ratio	-	1.60	1.66	1.57	1.48	1.78
Return on Equity (ROE)	-	12.68%	13.87%	14.93%	21.03%	35.81%
Return on Assets (ROA)	-	5.77%	6.83%	6.89%	9.07%	14.52%
Return on Capital (ROIC)	7.78%	7.55%	9.08%	9.44%	12.68%	21.04%
Return on Capital Employed (ROCE)	-	13.30%	16.20%	17.30%	22.70%	33.20%
Earnings Yield	4.20%	5.38%	4.30%	5.32%	5.16%	4.33%
FCF Yield	-	2.16%	3.32%	-1.01%	-2.05%	1.03%
Dividend Yield	0.20%	0.29%	0.23%	0.30%	0.24%	0.36%
Payout Ratio	-	5.39%	5.41%	5.65%	4.64%	8.28%
Buyback Yield / Dilution	0.78%	0.32%	0.72%	-	0.64%	-
Total Shareholder Return	0.99%	0.61%	0.95%	0.30%	0.88%	0.36%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.